| scholarly article | Q13442814 |
| P50 | author | Peter Calabresi | Q7173149 |
| Sanjay C Keswani | Q125266808 | ||
| Ronald L Schnaar | Q42852048 | ||
| Guo-Li Ming | Q46050523 | ||
| Hongjun Song | Q46050928 | ||
| Ahmet Hoke | Q55135740 | ||
| Giorgia Melli | Q56705834 | ||
| P2093 | author name string | Katherine Conant | |
| John W Griffin | |||
| Thien Nguyen | |||
| Melina Jones | |||
| Kee-Jun Kim | |||
| Niraj R Mehta | |||
| P2860 | cites work | Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration | Q24290847 |
| Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells | Q67531806 | ||
| Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication | Q68682017 | ||
| Development of sympathetic neurons in compartmentalized cultures. II. Local control of neurite survival by nerve growth factor | Q70479323 | ||
| Myelin from MAG-deficient mice is a strong inhibitor of neurite outgrowth | Q71305186 | ||
| Epidermal denervation and its effects on keratinocytes and Langerhans cells | Q71763766 | ||
| Regional modulation of neurofilament organization by myelination in normal axons | Q72816493 | ||
| Cutaneous nerve degeneration induced by acrylamide in mice | Q73088607 | ||
| Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with charcot-marie-tooth disease 1A duplication | Q74015122 | ||
| Axonal pathology in demyelinating diseases | Q77813491 | ||
| NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth | Q24301480 | ||
| LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex | Q27919650 | ||
| Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor | Q28207833 | ||
| Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth | Q28216797 | ||
| Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily | Q28287516 | ||
| Myelin-associated glycoprotein interacts with neurons via a sialic acid binding site at ARG118 and a distinct neurite inhibition site | Q28565889 | ||
| Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells | Q28575758 | ||
| Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury | Q28585186 | ||
| Axonal transection in the lesions of multiple sclerosis | Q29615585 | ||
| Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. | Q33907007 | ||
| Axon pathology in neurological disease: a neglected therapeutic target | Q34831556 | ||
| Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease | Q35057231 | ||
| Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging | Q35483352 | ||
| Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival | Q35613392 | ||
| Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. | Q35751923 | ||
| Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin | Q36205816 | ||
| Individual microtubules in the axon consist of domains that differ in both composition and stability | Q36223418 | ||
| The neurofilament middle molecular mass subunit carboxyl-terminal tail domains is essential for the radial growth and cytoskeletal architecture of axons but not for regulating neurofilament transport rate | Q36324735 | ||
| Cleavage of myelin associated glycoprotein by matrix metalloproteinases | Q36513220 | ||
| Biology and pathology of nonmyelinating Schwann cells | Q37273612 | ||
| Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein | Q38362117 | ||
| Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. | Q41712768 | ||
| Rho kinase inhibition enhances axonal regeneration in the injured CNS. | Q44323471 | ||
| Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsies. | Q44846411 | ||
| A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging--evidence of Wallerian degeneration. | Q48364190 | ||
| The inhibition site on myelin-associated glycoprotein is within Ig-domain 5 and is distinct from the sialic acid binding site. | Q51795157 | ||
| Myelin-associated glycoprotein modulates expression and phosphorylation of neuronal cytoskeletal elements and their associated kinases. | Q52546399 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 630-637 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Axonal protective effects of the myelin-associated glycoprotein | |
| P478 | volume | 29 |
| Q47850611 | A Panel of Autoantibodies Against Neural Proteins as Peripheral Biomarker for Pesticide-Induced Neurotoxicity |
| Q35923499 | A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis. |
| Q36162026 | A novel system to accelerate the progression of nerve degeneration in transgenic mouse models of neuropathies |
| Q38974294 | Accelerated neuronal differentiation toward motor neuron lineage from human embryonic stem cell line (H9) |
| Q37249167 | Acetyltransferases (HATs) as targets for neurological therapeutics |
| Q22251261 | Alzheimer's disease as homeostatic responses to age-related myelin breakdown |
| Q34400945 | An essential role of MAG in mediating axon-myelin attachment in Charcot-Marie-Tooth 1A disease |
| Q51371715 | Anti-MAG autoantibodies are increased in Parkinson's disease but not in atypical parkinsonism. |
| Q41970450 | Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice |
| Q34384966 | Axon growth inhibition by RhoA/ROCK in the central nervous system |
| Q38248881 | Axon plasticity in the mammalian central nervous system after injury |
| Q34170562 | Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease. |
| Q52603055 | Cerebral ischemia and neuroregeneration. |
| Q28655689 | Collaborative models for translational neuroscience and rehabilitation research |
| Q35164094 | Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo |
| Q38175969 | Concepts for regulation of axon integrity by enwrapping glia |
| Q36912268 | Conduction block in PMP22 deficiency. |
| Q37849455 | Critical appraisal of animal models of multiple sclerosis |
| Q37775522 | Dorsal Root Ganglia Sensory Neuronal Cultures: a tool for drug discovery for peripheral neuropathies. |
| Q24630696 | Enhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the network |
| Q37867334 | Enhancing remyelination in disease--can we wrap it up? |
| Q39049796 | FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease. |
| Q37878442 | High-performance separation techniques hyphenated to mass spectrometry for ganglioside analysis. |
| Q54383932 | Inhibition of CNS remyelination by the presence of semaphorin 3A. |
| Q37557188 | Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination. |
| Q28084579 | Insights into the physiological role of CNS regeneration inhibitors |
| Q26269842 | Latrophilins function as heterophilic cell-adhesion molecules by binding to teneurins: regulation by alternative splicing |
| Q24631557 | Loss of the E3 ubiquitin ligase LRSAM1 sensitizes peripheral axons to degeneration in a mouse model of Charcot-Marie-Tooth disease |
| Q92895842 | Monocarboxylate transporter 1 in Schwann cells contributes to maintenance of sensory nerve myelination during aging |
| Q26797407 | Myelin damage and repair in pathologic CNS: challenges and prospects |
| Q57957934 | Myelin matters: proteomic insights into white matter disorders |
| Q38718081 | Myelin regulatory factor drives remyelination in multiple sclerosis |
| Q40232772 | Myelin-associated glycoprotein (MAG) protects neurons from acute toxicity using a ganglioside-dependent mechanism. |
| Q35928869 | Myelin-associated glycoprotein gene and brain morphometry in schizophrenia |
| Q28115733 | Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder |
| Q28591610 | Myelin-associated glycoprotein modulates apoptosis of motoneurons during early postnatal development via NgR/p75(NTR) receptor-mediated activation of RhoA signaling pathways |
| Q34686899 | Myelin-associated glycoprotein protects neurons from excitotoxicity |
| Q38194402 | Myelin-associated inhibitors in axonal growth after CNS injury |
| Q37808620 | Myelination and support of axonal integrity by glia |
| Q83162670 | Myelination and the trophic support of long axons |
| Q38020375 | Neural regeneration: lessons from regenerating and non-regenerating systems. |
| Q27024005 | Neuroimmune activation and myelin changes in adolescent rats exposed to high-dose alcohol and associated cognitive dysfunction: a review with reference to human adolescent drinking |
| Q41117575 | Neurologic syndrome associated with homozygous mutation at MAG sialic acid binding site |
| Q38048610 | Neuroprotection and repair in multiple sclerosis |
| Q38615259 | Nogo receptor 1 regulates Caspr distribution at axo-glial units in the central nervous system |
| Q26780518 | Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update |
| Q38005573 | Ophthalmic transplantology: anterior segment of the eye - part I. |
| Q38137792 | Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology. |
| Q50501021 | Platelet-derived growth factor-responsive neural precursors give rise to myelinating oligodendrocytes after transplantation into the spinal cords of contused rats and dysmyelinated mice. |
| Q37718924 | Progesterone reduces secondary damage, preserves white matter, and improves locomotor outcome after spinal cord contusion |
| Q33670947 | Promising treatments of tomorrow for multiple sclerosis |
| Q40515513 | Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking |
| Q34279119 | Quaking I controls a unique cytoplasmic pathway that regulates alternative splicing of myelin-associated glycoprotein |
| Q35827478 | Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system |
| Q26745419 | Regulating Axonal Responses to Injury: The Intersection between Signaling Pathways Involved in Axon Myelination and The Inhibition of Axon Regeneration |
| Q46614637 | Regulation and dysregulation of axon infrastructure by myelinating glia. |
| Q39420410 | Remyelination therapies: a new direction and challenge in multiple sclerosis |
| Q37877302 | Role of myelin-associated inhibitors in axonal repair after spinal cord injury |
| Q33771091 | Roles of channels and receptors in the growth cone during PNS axonal regeneration |
| Q26995291 | Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration |
| Q37652733 | Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction |
| Q38098567 | Spinal cord regeneration: where fish, frogs and salamanders lead the way, can we follow? |
| Q37198963 | Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system |
| Q38763357 | The Glia Response after Peripheral Nerve Injury: A Comparison between Schwann Cells and Olfactory Ensheathing Cells and Their Uses for Neural Regenerative Therapies. |
| Q30514561 | The lateral thoracic nerve and the cutaneous maximus muscle--a novel in vivo model system for nerve degeneration and regeneration studies |
Search more.